ADARx (ADRX) CPO Robert Ackles Receives Stock Award

What Happened

• Robert William Ackles, Chief People Officer of ADARx Pharmaceuticals (ADRX), received a grant of 85,346 derivative shares on 2026-09-24. The award is reported at $0.00 per share (no cash paid) as a derivative grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-24; Form 4 filed: 2026-09-28.
• Security: 85,346 shares granted as a derivative award (code A — grant/award).
• Price: $0.00 per share; reported total value: $0 (derivative award).
• Vesting: 1/4th vests on 2027-09-24; remaining shares vest in equal quarterly installments over the next three years, subject to continued service (per footnote).
• Shares owned after the transaction: not specified in this filing.
• No late-filing flag noted in the provided record.

Context

• This appears to be a compensation-related equity award (likely RSUs or similar) for future vesting and does not represent an immediate market purchase or sale. Such awards are common for executive compensation and do not by themselves indicate insider buying or selling intent.